Literature DB >> 28534707

Type IA topoisomerases can be "magicians" for both DNA and RNA in all domains of life.

Muzammil Ahmad1, Dongyi Xu2, Weidong Wang1.   

Abstract

Topoisomerases solve critical topological problems in DNA metabolism and have long been regarded as the "magicians" of the DNA world. Here we present views from 2 of our recent studies indicating that Type IA topoisomerases from all domains of life often possess dual topoisomerase activities for both DNA and RNA. In animals, one of the 2 Type IA topoisomerases, Top3β, contains an RNA-binding domain, possesses RNA topoisomerase activity, binds mRNAs, interacts with mRNA-binding proteins, and associates with active mRNA translation machinery. The RNA-binding domain is required for Top3β to bind mRNAs and promote normal neurodevelopment. Top3β forms a highly conserved complex with Tudor-domain-containing 3 (TDRD3), a protein known to interact with translation factors, histones, RNA polymerase II, single stranded DNA and RNA. Top3β requires TDRD3 for its association with the mRNA translation machinery. We suggest that Type IA topoisomerases can be "magicians" for not only DNA, but also RNA; and they may solve topological problems for both nucleic acids in all domains of life. In animals, Top3β-TDRD3 is a dual-activity topoisomerase complex that can act on DNA to stimulate transcription, and on mRNA to promote translation.

Entities:  

Keywords:  FMRP; TDRD3; Top3α; Top3β; polyribosomes; topoisomerase

Mesh:

Substances:

Year:  2017        PMID: 28534707      PMCID: PMC5546716          DOI: 10.1080/15476286.2017.1330741

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  62 in total

1.  Did DNA replication evolve twice independently?

Authors:  D D Leipe; L Aravind; E V Koonin
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

2.  RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability.

Authors:  Dongyi Xu; Rong Guo; Alexandra Sobeck; Csanad Z Bachrati; Jay Yang; Takemi Enomoto; Grant W Brown; Maureen E Hoatlin; Ian D Hickson; Weidong Wang
Journal:  Genes Dev       Date:  2008-10-15       Impact factor: 11.361

3.  Probing the structural domains and function in vivo of Escherichia coli DNA topoisomerase I by mutagenesis.

Authors:  L Zumstein; J C Wang
Journal:  J Mol Biol       Date:  1986-10-05       Impact factor: 5.469

4.  Human topoisomerase IIIalpha is a single-stranded DNA decatenase that is stimulated by BLM and RMI1.

Authors:  Jay Yang; Csanad Z Bachrati; Jiongwen Ou; Ian D Hickson; Grant W Brown
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

5.  Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function.

Authors:  Y Q Zhang; A M Bailey; H J Matthies; R B Renden; M A Smith; S D Speese; G M Rubin; K Broadie
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

6.  Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.

Authors:  Alfredo Castello; Bernd Fischer; Katrin Eichelbaum; Rastislav Horos; Benedikt M Beckmann; Claudia Strein; Norman E Davey; David T Humphreys; Thomas Preiss; Lars M Steinmetz; Jeroen Krijgsveld; Matthias W Hentze
Journal:  Cell       Date:  2012-05-31       Impact factor: 41.582

7.  Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.

Authors:  Bastian Linder; Oliver Plöttner; Matthias Kroiss; Enno Hartmann; Bernhard Laggerbauer; Gunter Meister; Eva Keidel; Utz Fischer
Journal:  Hum Mol Genet       Date:  2008-07-28       Impact factor: 6.150

8.  Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders.

Authors:  Georg Stoll; Olli P H Pietiläinen; Bastian Linder; Jaana Suvisaari; Cornelia Brosi; William Hennah; Virpi Leppä; Minna Torniainen; Samuli Ripatti; Sirpa Ala-Mello; Oliver Plöttner; Karola Rehnström; Annamari Tuulio-Henriksson; Teppo Varilo; Jonna Tallila; Kati Kristiansson; Matti Isohanni; Jaakko Kaprio; Johan G Eriksson; Olli T Raitakari; Terho Lehtimäki; Marjo-Riitta Jarvelin; Veikko Salomaa; Matthew Hurles; Hreinn Stefansson; Leena Peltonen; Patrick F Sullivan; Tiina Paunio; Jouko Lönnqvist; Mark J Daly; Utz Fischer; Nelson B Freimer; Aarno Palotie
Journal:  Nat Neurosci       Date:  2013-08-04       Impact factor: 24.884

9.  The C-terminal domain of RNA polymerase II is modified by site-specific methylation.

Authors:  Robert J Sims; Luis Alejandro Rojas; David B Beck; Roberto Bonasio; Roland Schüller; William J Drury; Dirk Eick; Danny Reinberg
Journal:  Science       Date:  2011-04-01       Impact factor: 47.728

10.  The role of the Zn(II) binding domain in the mechanism of E. coli DNA topoisomerase I.

Authors:  Adriana Ahumada; Yuk-Ching Tse-Dinh
Journal:  BMC Biochem       Date:  2002-05-29       Impact factor: 4.059

View more
  14 in total

Review 1.  The many lives of type IA topoisomerases.

Authors:  Anna H Bizard; Ian D Hickson
Journal:  J Biol Chem       Date:  2020-04-10       Impact factor: 5.157

2.  A dual-activity topoisomerase complex regulates mRNA translation and turnover.

Authors:  Shuaikun Su; Yutong Xue; Alexei Sharov; Yongqing Zhang; Seung Kyu Lee; Jennifer L Martindale; Wen Li; Wai Lim Ku; Keji Zhao; Supriyo De; Weiping Shen; Payel Sen; Myriam Gorospe; Dongyi Xu; Weidong Wang
Journal:  Nucleic Acids Res       Date:  2022-06-24       Impact factor: 19.160

3.  Topoisomerase Assays.

Authors:  John L Nitiss; Kostantin Kiianitsa; Yilun Sun; Karin C Nitiss; Nancy Maizels
Journal:  Curr Protoc       Date:  2021-10

4.  Mechanistic insights from structure of Mycobacterium smegmatis topoisomerase I with ssDNA bound to both N- and C-terminal domains.

Authors:  Nan Cao; Kemin Tan; Xiaobing Zuo; Thirunavukkarasu Annamalai; Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

5.  Topoisomerase 3β interacts with RNAi machinery to promote heterochromatin formation and transcriptional silencing in Drosophila.

Authors:  Seung Kyu Lee; Yutong Xue; Weiping Shen; Yongqing Zhang; Yuyoung Joo; Muzammil Ahmad; Madoka Chinen; Yi Ding; Wai Lim Ku; Supriyo De; Elin Lehrmann; Kevin G Becker; Elissa P Lei; Keji Zhao; Sige Zou; Alexei Sharov; Weidong Wang
Journal:  Nat Commun       Date:  2018-11-23       Impact factor: 14.919

6.  Regulatory Effect of DNA Topoisomerase I on T3SS Activity, Antibiotic Susceptibility and Quorum- Sensing-Independent Pyocyanin Synthesis in Pseudomonas aeruginosa.

Authors:  Rong Yan; Shikun Hu; Ning Ma; Peiqing Song; Qingqing Liang; Huiqun Zhang; Yanqi Li; Lixin Shen; Kangmin Duan; Lin Chen
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

Review 7.  Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.

Authors:  Mateusz Kciuk; Beata Marciniak; Renata Kontek
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

8.  DNA and RNA Cleavage Complexes and Repair Pathway for TOP3B RNA- and DNA-Protein Crosslinks.

Authors:  Sourav Saha; Yilun Sun; Shar-Yin Naomi Huang; Simone Andrea Baechler; Lorinc Sandor Pongor; Keli Agama; Ukhyun Jo; Hongliang Zhang; Yuk-Ching Tse-Dinh; Yves Pommier
Journal:  Cell Rep       Date:  2020-12-29       Impact factor: 9.423

9.  Loss of TOP3B leads to increased R-loop formation and genome instability.

Authors:  Tao Zhang; Mathew Wallis; Vida Petrovic; Jackie Challis; Paul Kalitsis; Damien F Hudson
Journal:  Open Biol       Date:  2019-12-04       Impact factor: 6.411

Review 10.  Mechanism of Type IA Topoisomerases.

Authors:  Tumpa Dasgupta; Shomita Ferdous; Yuk-Ching Tse-Dinh
Journal:  Molecules       Date:  2020-10-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.